BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2018
View Archived Issues
Ionis licenses IONIS-AZ5-2.5Rx to AstraZeneca
Read More
Wave Life Sciences forms global CNS collaboration with Takeda
Read More
MSD and Viralytics enter definitive acquisition agreement to advance immuno-oncology pipeline
Read More
AbbVie announces topline results from phase III trial of elagolix for uterine fibroids
Read More
Evofem Biosciences' Amphora granted FDA fast track designation for prevention of chlamydia
Read More
Researchers discover OAT-2068, a highly selective and orally bioavailable inhibitor of mCHIT1
Read More
BioArctic receives approval to include Estonian patients in SC-0806 trial in spinal cord injury
Read More
First patient dosed in Centrexion's phase III trial of CNTX-4975 for moderate to severe knee OA pain
Read More
Medshine Discovery divulges new compounds for cytomegalovirus infection
Read More
Suzhou Guokuang Pharmtech, Hangzhou Adlai Nortye Pharmaceutical Technology patent IDO/TDO inhibitors
Read More
Novel SSAO inhibitors discovered at Lilly
Read More
Phase II data presented for RM-1929 photoimmunotherapy in patients with rHNSCC
Read More
Shenzhen Targetrx Biotechnology describes new HCV NS3/NS4A inhibitors
Read More
Erleada available to order in U.S. through Biologics
Read More
Phase IIa study of GWP-42006 in adults with focal seizures did not meet its primary endpoint
Read More
STA Pharmaceutical and Regulus sign oligonucleotide synthesis collaboration agreement
Read More
Phase III study of Mesoblast's remestemcel-L in acute GvHD meets primary endpoint
Read More
NIAID initiates phase I study of MERS-CoV antibodies REGN-3048 and REGN-3051
Read More
Endoscopic and symptom improvement seen with apremilast in phase II ulcerative colitis trial
Read More
EMA committee communicates positive trend vote for rucaparib
Read More
Vertex announces phase III study of VX-659, tezacaftor and ivacaftor for cystic fibrosis
Read More
TopiVert presents phase I data for TOP-1288 in healthy volunteers
Read More
Mouse model reveals role of the OTUD7A gene in 15q13.3 microdeletion syndrome
Read More
Tenofovir exalidex granted U.S. orphan designation for pediatric HBV infection
Read More
Tell us about your experience with TRDN
Read More